Frank Lammert
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study
Beigel F, Brand S, Göke B, Rust C, Breiteneicher S, Maul J, Lammert F, Howaldt S, Teich N, Ochsenkühn T. Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study. J Crohns Colitis 2014; 8:1471-9.
Jun 19, 2014Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study
Jun 19, 2014J Crohns Colitis 2014; 8:1471-9
Beigel Florian, Brand Stephan, Göke Burkhard, Rust Christian, Breiteneicher Simone, Maul Jochen, Lammert Frank, Howaldt Stefanie, Teich Niels, Ochsenkühn Thomas
Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats
Trebicka J, Sauerbruch T, Lammert F, Clemens C, Biener A, Fischer N, Eckhardt A, Biecker E, Hennenberg M, Leifeld L, Heller J. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 2008; 47:1264-76.
Apr 26, 2008Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats
Apr 26, 2008Hepatology 2008; 47:1264-76
Trebicka Jonel, Sauerbruch Tilman, Lammert Frank, Clemens Christoph, Biener Andrea, Fischer Nicolas, Eckhardt Andreas, Biecker Erwin, Hennenberg Martin, Leifeld Ludger, Heller Jörg